Are Twist Bioscience Corp (TWST) stocks a prudent buy?

A share price of Twist Bioscience Corp [TWST] is currently trading at $45.52, up 0.22%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The TWST shares have gain 12.78% over the last week, with a monthly amount glided 9.82%, and seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Twist Bioscience Corp [NASDAQ: TWST] stock has seen the most recent analyst activity on June 04, 2024, when Guggenheim initiated its Buy rating and assigned the stock a price target of $53. Previously, Goldman upgraded its rating to Buy on January 17, 2024, and elevated its price target to $45. On September 27, 2023, Berenberg initiated with a Buy rating and assigned a price target of $27 on the stock. Scotiabank started tracking the stock assigning a Sector Outperform rating and suggested a price target of $33 on January 05, 2023. Evercore ISI upgraded its rating to a Outperform and raised its price target to $36 on January 03, 2023.

Twist Bioscience Corp experienced fluctuations in its stock price throughout the past year between $15.85 and $60.90. Currently, Wall Street analysts expect the stock to reach $42.4 within the next 12 months. Twist Bioscience Corp [NASDAQ: TWST] shares were valued at $45.52 at the most recent close of the market. An investor can expect a potential drop of -6.85% based on the average TWST price forecast.

Analyzing the TWST fundamentals

Trailing Twelve Months sales for Twist Bioscience Corp [NASDAQ:TWST] were 295.21M which represents 27.81% growth. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at -0.64%, Pretax Profit Margin comes in at -0.74%, and Net Profit Margin reading is -0.75%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -0.39 and Total Capital is -0.34. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.18.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 44.95 points at the first support level, and at 44.39 for the second support level. However, for the 1st resistance point, the stock is sitting at 46.45, and for the 2nd resistance point, it is at 47.39.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Twist Bioscience Corp [NASDAQ:TWST] is 4.91. Also, the Quick Ratio is 4.52, while the Cash Ratio stands at 3.24. Considering the valuation of this stock, the price to sales ratio is 9.03, the price to book ratio is 5.42.

Transactions by insiders

Recent insider trading involved Leproust Emily M., Officer, that happened on Nov 06 ’24 when 14334.0 shares were purchased. Officer, Laponis Adam completed a deal on Nov 06 ’24 to buy 4160.0 shares. Meanwhile, Officer WERNER ROBERT F. bought 1448.0 shares on Nov 06 ’24.

Related Posts